Germitec Appoints Keith Koby as President of North America

Germitec, a pioneering French Medtech company specializing in High-Level Disinfection (HLD) for ultrasound probes through its proprietary UV-C technology, has appointed Keith Koby as President of North America.
 
Koby brings over 30 years of experience in the North American Medtech industry, including leadership roles at GE Healthcare and Nanosonics. Most recently, Koby helped grow HeraMED’s business in the US, optimizing its go-to-market strategy, and overseeing the largest deployment of their FDA-approved telehealth solution.
 
He will leverage his expertise in building commercial teams as Germitec rapidly expands its US presence. Koby will lead the company’s entry into the US High-Level Disinfection market for ultrasound probes and its long-term commercial development.
 
Vincent Gardès, Chief Executive Officer of Germitec, added: “We are thrilled to welcome Keith as we launch our Chronos automated disinfection device in the largest healthcare market. Keith’s experience and proven track record are tremendous assets to the Germitec team. With De Novo clearance, we are well-positioned to complete our next financing round and scale rapidly in the USA, while continuing to expand in other regions and lead the way in UV-C High-Level Disinfection technology.”
 
Keith Koby, President, North America, stated: “I am honored to join Germitec’s world-class team and lead the launch of Chronos across North America. Starting now, we are offering healthcare facilities a groundbreaking, chemical-free cost-saving technology. Our goal is to have Chronos in every department where ultrasound exams are conducted.”
 
Germitec’s Chronos uses patented UV-C technology, proven to be both safe and effective through the rigorous FDA De Novo process. Designed for placement in exam rooms, close to ultrasound machines, Chronos enhances patient workflow, allowing healthcare providers to see more patients while ensuring a high standard of care. The intuitive interface enables seamless data storage, viewing, and downloading, ensuring complete disinfection traceability.
 
Germitec’s environmentally friendly technology reduces human error and enhances the safety of the High-Level Disinfection process by controlling key parameters such as dose, temperature, and time.
 
With a market opportunity of 60,000 units in the US, Germitec is poised to quickly capture market share.